Drimva

Legend Biotech

Manufacturing Lead Operator, Aseptic Process

$84K–$110K

Raritan, New Jersey, United States · Full-time · Posted Sep 28, 2026

Experience
Minimum 2 years of operations experience in a biotech/biopharma cGMP environment; manufacturing, maintenance, quality, testing, or engineering experience required.
Education
Bachelor’s degree in life science/engineering or related field, or equivalent experience.
Visa sponsorship
Applicants must be authorized to work in the United States; the employer participates in E-Verify.

About the job

Leads and performs aseptic CAR-T manufacturing operations in a cGMP cleanroom, supporting clinical and commercial production, process improvement, and product quality.

What you'll do

  • Oversee production-floor activities and perform cell culture, purification, aseptic processing, and cryopreservation in ISO 5 and ISO 7 environments.
  • Troubleshoot patient-specific product and process issues; support process development, continuous improvement, and corrective and preventive actions.
  • Record production data according to procedures and batch records, and collaborate with Manufacturing, Engineering, Quality, and other stakeholders.

What they ask for

  • Bachelor’s degree in life science/engineering or related field, or equivalent experience.
  • At least 2 years of operations experience in a biotech/biopharma cGMP environment; experience in manufacturing, maintenance, quality, testing, or engineering.
  • Knowledge of cGMP regulations and FDA guidance related to manufacturing cell-based products.
  • Ability to handle human-derived materials in a BSL-2 cleanroom and accommodate shift work, including evenings and weekends, and unplanned overtime.

Nice to have

  • Prior experience in an aseptic manufacturing environment.

Pay

$83,711 — $109,870 USD (base pay)

Tools

CAR-T, cGMP, ISO 5, ISO 7, BSL2+, FDA

AI focus

Working knowledge of AI technologies and approved AI tools; use them responsibly to improve productivity and decision-making, apply human oversight to AI-generated outputs, and follow organizational AI policies.

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)